Georgetown researchers find that landmark Medicare law had little impact on reducing chemotherapy cost

Legislation passed in 2003 to slow the spiraling costs of drugs paid for by the federal government to treat Medicare patients has had no meaningful impact on cancer chemotherapy drug costs, say a team of researchers in the Journal of Clinical Oncology published online today. …read more

Source: Cancer